Excitingly, several research groups have reported that high-level infiltration of immune effector cell populations, including CD8+ cytotoxic T-lymphocytes (CTLs), into the TME can improve response to ICPIs in GBM [12, 13]. The gene discussed is CD8A; the disease is glioblastoma.